Citigroup’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-100,000
Closed -$581K 5909
2022
Q3
$581K Buy
+100,000
New +$574K ﹤0.01% 3132
2020
Q1
Sell
-1,100
Closed -$6K 7732
2019
Q4
$6K Buy
1,100
+600
+120% +$3.05K ﹤0.01% 7355
2019
Q3
$3K Hold
500
﹤0.01% 7475
2019
Q2
$3K Sell
500
-6,500
-93% -$45.6K ﹤0.01% 7571
2019
Q1
$51K Sell
7,000
-2,600
-27% -$18.8K ﹤0.01% 6329
2018
Q4
$71K Buy
9,600
+7,100
+284% +$45K ﹤0.01% 5946
2018
Q3
$14K Buy
+2,500
New +$10.7K ﹤0.01% 7242
2017
Q4
Sell
-10,300
Closed -$54K 7625
2017
Q3
$54K Buy
10,300
+3,500
+51% +$15K ﹤0.01% 5960
2017
Q2
$24K Buy
6,800
+4,300
+172% +$17.3K ﹤0.01% 6194
2017
Q1
$13K Buy
+2,500
New +$12.2K ﹤0.01% 6467
2016
Q3
Sell
-500
Closed -$4K 7149
2016
Q2
$4K Buy
+500
New +$4.57K ﹤0.01% 6825

Other funds holding PACB